Associate Vice President
Eli Lilly and Company
Indianapolis, United States
Wei Zhou is currently Associate Vice President and Head of Oncology, at Lilly Value, Evidence, and Outcomes (VEO). Before that, he was the Executive Director and Head of Oncology at Merck Epidemiology Department, Executive Director at Merck CORE Product Line, Head of Epidemiology Asia Pacific Unit at Merck, Director of Molecular Epidemiology at Pfizer Oncology, and Senior Epidemiologist at Merck. Wei was a Research Fellow/Research Associate/ Research Scientist at Harvard School of Public Health between June 1999 and December 2007. Wei is a Fellow, previous Board Member and Vice President for Finance, and previous co-lead of the Real-World Evidence Task Force of the International Society of Pharmacoepidemiology (ISPE).
Wei received his MD from West China University of Medical Sciences in 1994 and Ph.D. of Environmental Health from Shanghai Medical University in 1998. He was the recipient of the John E. Fogarty International Training and Research Program. He has published more than 90 peer-reviewed manuscripts and book chapters and served as a reviewer for various international journals. Wei has given numerous presentations and served as chair/co-chair at different international conferences and symposiums. Wei is a well-known expert in the fields of cancer epidemiology, molecular epidemiology, Outcome Research, and real-world evidence research.
Disclosure information not submitted.
Cancer Pharmacoepidemiology and Genomics: What You Should Know in the Era of Precision Medicine
Wednesday, August 23, 2023
2:00 PM – 6:00 PM ADT
